Malignant Male Reproductive System Neoplasm

Malignant Male Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,451
Recruiting: 784
Ph III recruiting: 82
Growth YoY: +24.4%
Industry share: 18%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (762)

clinicaltrialsPublishedShowing 51–100 of 280 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06654336	Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)(RATIONAL)	recruiting	Phase 2	162	Ontario Clinical Oncology Group (OCOG)OTHER	1	Aug 31, 2026	clinicaltrials
NCT07111507	A Study of Tarlatamab for People With Prostate Cancer	recruiting	Phase 2	32	Memorial Sloan Kettering Cancer CenterOTHER	1